Working with some of the world’s largest pharmaceutical and consumer product companies, we have a track record of collaborating from initial product concept through commercial GMP manufacture by leveraging our technologies, formulation and development expertise.
We welcome the opportunity to solve complex transdermal challenges that create new markets with first-in-patch products.
Corium is currently seeking strategic partnerships in the following areas:
- Commercial marketing rights outside the United States for our Corplex™ Donepezil and Corplex Memantine product candidates for the treatment of Alzheimer’s disease; and
- The evaluation, development, and commercialization of new products combining our Corplex and/or MicroCor delivery systems with our partner’s proprietary molecules.
In addition, we look forward to speaking with potential partners regarding manufacturing opportunities for other transdermal products.
Please for more information.
The safety and efficacy of the products under investigation have not been established. There is no assurance that any of these investigational products will receive health authority approval or become commercially available in any country.